JULIA CAOUETTE: Open Payments
NPI 1801502323 · MOOSUP, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 53 payments from 16 companies in 2025. Trend: 2023 $834 · 2024 $753 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $218 |
| GlaxoSmithKline, LLC. | 7 | $214 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $122 |
| Exact Sciences Corporation | 4 | $117 |
| Phathom Pharmaceuticals, Inc. | 1 | $85 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Novo Nordisk Inc | 4 | $67 |
| Gilead Sciences, Inc. | 3 | $65 |
| PFIZER INC. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
Products named: PENMENVY, VRAYLAR, CAPLYTA, VOQUEZNA, FANAPT, QULIPTA, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across CT — which companies pay providers there.
